MedTrace Logo

Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting

NCT03387956 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2018-06-06

No results posted yet for this study

Summary

optimal postoperative pain control with intrathecal morphine, with proper prevention of postoperative nausea and vomiting. Dexamethasone, and or atropine could offer some protection against nausea and vomiting.

Conditions

  • Postoperative Nausea

Interventions

DRUG

Intrathecal atropine

100ug intrathecal atropine will be injected with spinal anesthesia

DRUG

dexamethasone

intravenous 8 mg dexamethasone (2ml).

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2017-07-28
Completion
2017-08-10

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03387956 on ClinicalTrials.gov